Trulieve Posts $224.1 Million In Q3 Revenues, Positive Net Income
Trulieve Cannabis (CSE: TRUL) this morning reported its third quarter financial results for 2021. The company posted revenues of $224.1
Read more
Trulieve
Trulieve: Analysts Expect US$221 Million In Q3 Revenues
Trulieve (CSE: TRUL) announced that they will be reporting their third quarter financials before the market opens on November 15th.
Read more
Haywood Reiterates $80 Price Target On Trulieve After Harvest Health Purchase
On October 1st, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition of Harvest Health. Harvest shareholders
Read more
Trulieve: Canaccord Retains $97 Price Target Following Harvest Health Transaction
On October 1, Trulieve Cannabis (CSE: TRUL) announced that they completed their $1.75 billion acquisition of Harvest Health (CSE: HARV).
Read more
Trulieve Looks To Raise US$350 Million In Senior Secured Notes To Pay Off Harvest Health Debts
Trulieve Cannabis (CSE: TRUL) last night revealed they are looking to raise big dollars as a means of paying for
Read more
Planet 13 Acquires Florida License From Harvest Health
Planet 13 Holdings (CSE: PLTH) is officially headed to Florida. The firm this morning indicated that it has officially acquired
Read more
Trulieve Cannabis Closes Acquisition Of Harvest Health
Trulieve Cannabis (CSE: TRUL) has finally completed the acquisition of Harvest Health (CSE: HARV). It was announced this morning that
Read more
Trulieve, Harvest Health Receive Court Approval For Merger, Closing Timeline Remains Vague
Approval from the courts has been granted to Harvest Health (CSE: HARV) in relation to its acquisition by Trulieve Cannabis
Read more
Harvest Health Shareholders Approve Transaction With Trulieve Cannabis
It appears that Harvest health (CSE: HARV) and Trulieve Cannabis (CSE: TRUL) are set to become one. Last night, Harvest
Read more
Trulieve Posts Q1 Revenues Of $215.1 Million, Net Income
Trulieve Cannabis (CSE: TRUL) this morning reported its second quarter financial results, healthily beating analyst consensus estimates. The company reported
Read more